


David Nurek
Independent non-executive chairman
The group’s intense focus on the delivery of its strategy over the past year has reaped handsome rewards for all stakeholders.
On the trading front, the strong growth in turnover has ensured that all the businesses increased market share, while the 35.8% increase in operating profit reflects the improved turnover, margin and operating efficiencies.
Headline earnings increased by 41.9% to R356.9 million with diluted headline earnings per share growing 45.1% to 103.0 cents per share.
The improving performance has attracted increasing interest from the investment community which saw the share price move 47% for the year compared to the 35% growth in the General Retailers Index and a 31% rise in the All Share Index.
Shareholder wealth has been enhanced by R1.6 billion, including the growth in the market capitalisation and distributions to shareholders which were 45.2% higher than 2006.
The board is confident that the group’s strategy is appropriate for the ongoing creation of shareholder value and believes that the strategy is working effectively, based on the performance in the past two years. Management has identified five strategic priorities and business plans are focused on the delivery of these priorities:
After embracing the Department of Health’s announcement of a new dispensing fee structure in late 2006 we were disappointed when these regulations were challenged in court by independent pharmacists and the planned implementation date postponed.
A year later there is still no clarity on dispensing fees for retail pharmacy and this has only added costs for consumers, while negatively impacting the pharmacy profession.
Despite the legislative uncertainty Clicks continues to build a sustainable pharmacy business at its current low pricing levels.
The regulatory landscape for pharmaceutical wholesalers is also in a state of flux. We anticipate draft regulations on international benchmark pricing being released in the coming months. The capping of logistics fees in the single exit pricing environment is expected to be introduced once benchmark pricing has been promulgated.
We have also urged the health authorities to address the registration criteria for wholesalers operating in the pharmaceutical market. The proliferation of quasi-wholesalers continues unabated and there are now over 100 registered wholesalers. We firmly believe that more exacting standards need to be adopted in this registration process.
New Clicks continues to support the government’s endeavours to make medicine more affordable and accessible to consumers and improve the quality of healthcare delivery. We remain committed to open and constructive engagement with the healthcare regulator.
Our longest serving director, Eliot Osrin, retired from the board at this year’s annual general meeting. While we paid tribute to Eliot in last year’s report, we thank him once again for his contribution as a director over more than a decade and wish him good health in his well-deserved retirement.
Independent non-executive director Lucia Swartz will not be making herself available for re-election at the forthcoming annual general meeting owing to increased work pressure. Lucia has served on the board for a combined seven years and we extend our appreciation for her contribution.
Management is committed to expanding both financial and non-financial reporting beyond the prescribed statutory requirements to enable shareholders to gain better insight into the business and make more informed decisions on share ownership. We have introduced Remuneration, Risk and Sustainability reports into the annual report for the first time this year while financial disclosure has been improved in several areas.
On behalf of the directors I would like to thank our key stakeholders for their support over the past year. This includes our shareholders and the broader investment community, our customers who have supported us in increasing numbers, suppliers, business partners, industry regulators and the media.
Thank you to my fellow directors and the management team of New Clicks, so ably led by David Kneale and his executive team of Keith Warburton, Michael Harvey and Bertina Engelbrecht.
In closing, congratulations to the more than 9 000 New Clicks employees in the stores across the country, the distribution facilities and at head office on a most creditable performance.
David Nurek
Independent non-executive chairman